About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDPhase 2/3NCT00598988

Acupuncture for Infectious Mononucleosis Trial

The purpose of this study is to investigate feasibility issues related to conducting an acupuncture study in a population of adolescents and young adults with infectious mononucleosis. Additionally, t...

Lead sponsor: University of Alberta•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Alberta

This study examines the feasibility of treating adolescents and young adults diagnosed with infectious mononucleosis with acupuncture. Additionally, this study will provide preliminary data regarding treatment parameters (acupuncture and standard care) and outcomes (i.e. fatigue).

Age

15 - 25 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•mono diagnosis confirmed by lab test
•21 days or less between start of symptoms and diagnostic test
•presence of fatigue of at least 4/11 (by Chalder Fatigue Questionnaire)
•no other illnesses present
•meets residency requirement

Exclusion Criteria

•insufficient communication in English
•unable to begin acupuncture within 21 days of diagnostic test
•acupuncture use currently or in the preceding 3 months
•currently under the care of a TCM practitioner
•unwilling to be randomized

Related studies

Multi-Center Registry for ME/CFS

NCT05778006 · ME/CFS, CFS/ME, and more

Active Not RecruitingPhase 1

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

NCT04645147 · EBV, Epstein-Barr Virus Infection, and more

HIV Indicator Diseases in Hospital and Primary Care

NCT05225493 · HIV Infections, Primary Health Care, and more

COMPLETEDPhase 1/2

Controlled Trial of Valacyclovir in Infectious Mononucleosis

NCT00274404 · Infectious Mononucleosis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 11, 2022Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2/PHASE3

Enrollment3

Start dateJan 2008

Last updatedJul 11, 2022

Condition

Infectious Mononucleosis

Locations shown

University of Alberta

Edmonton, Alberta

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 11, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions